|
|
Prepublished online as a Blood First Edition Paper on May 29, 2003; DOI 10.1182/blood-2003-01-0273.

Submitted February 7, 2003
Accepted April 28, 2003
MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223)
Susanne Andreae, Sandrine Buisson, and Frederic Triebel*
Faculte de Pharmacie, Universite Paris-Sud, Chatenay-Malabry, France
* Corresponding author; email: Frederic.Triebel{at}cep.u-psud.fr.
Upon encountering a danger signal, DCs undergo a complex maturation process and become specialized in antigen presentation. We previously reported that engagement of MHC class II molecules located on immature DCs in membrane rafts by LAG-3 (CD223) leads to DC maturation. In contrast, exposure of DC to class II-specific mAb did not lead to maturation. Here we have investigated the signal transduction pathways involved in the LAG-3-induced maturation of human monocyte-derived DCs. We first show that areas of raft aggregation (both cholesterol-rich and CDw78 microdomains) could be visualized using a soluble LAG-3 protein and confocal microscopy. Engagement of class II by both its natural ligand LAG-3 and class II mAb induces rapid protein phosphorylation of PLC 2 and p72syk as well as activation of phosphatidyl inositol 3-kinase /Akt, p42/44 extra-cellular signal-regulated protein kinase and p38 mitogen-activated protein kinase pathways. Studies using inhibitors demonstrate that these three pathways are all important in inducing the maturation process of LAG-3-stimulated DCs. When class II molecules were ligated with LAG-3 versus specific antibody, differences in the phosphorylation pattern of c-Akt were observed. Thus, MHC class II signaling in DCs involves several pathways that have to be finely regulated to lead to cell activation and maturation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Brignone, B. Escudier, C. Grygar, M. Marcu, and F. Triebel
A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma
Clin. Cancer Res.,
October 1, 2009;
15(19):
6225 - 6231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Silva-Flannery, M. Cabrera-Mora, M. Dickherber, and A. Moreno
Polymeric Linear Peptide Chimeric Vaccine-Induced Antimalaria Immunity Is Associated with Enhanced In Vitro Antigen Loading
Infect. Immun.,
May 1, 2009;
77(5):
1798 - 1806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Liang, C. Workman, J. Lee, C. Chew, B. M. Dale, L. Colonna, M. Flores, N. Li, E. Schweighoffer, S. Greenberg, et al.
Regulatory T Cells Inhibit Dendritic Cells by Lymphocyte Activation Gene-3 Engagement of MHC Class II
J. Immunol.,
May 1, 2008;
180(9):
5916 - 5926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Casati, C. Camisaschi, L. Novellino, A. Mazzocchi, F. Triebel, L. Rivoltini, G. Parmiani, and C. Castelli
Human Lymphocyte Activation Gene-3 Molecules Expressed by Activated T Cells Deliver Costimulation Signal for Dendritic Cell Activation
J. Immunol.,
March 15, 2008;
180(6):
3782 - 3788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Brignone, C. Grygar, M. Marcu, K. Schakel, and F. Triebel
A Soluble Form of Lymphocyte Activation Gene-3 (IMP321) Induces Activation of a Large Range of Human Effector Cytotoxic Cells
J. Immunol.,
September 15, 2007;
179(6):
4202 - 4211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bayry, F. Triebel, S. V. Kaveri, and D. F. Tough
Human Dendritic Cells Acquire a Semimature Phenotype and Lymph Node Homing Potential through Interaction with CD4+CD25+ Regulatory T Cells
J. Immunol.,
April 1, 2007;
178(7):
4184 - 4193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Casati, C. Camisaschi, F. Rini, F. Arienti, L. Rivoltini, F. Triebel, G. Parmiani, and C. Castelli
Soluble Human LAG-3 Molecule Amplifies the In vitro Generation of Type 1 Tumor-Specific Immunity.
Cancer Res.,
April 15, 2006;
66(8):
4450 - 4460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Herrmann, C. T. Morita, K. Lee, and D. J. Kusner
Calmodulin kinase II regulates the maturation and antigen presentation of human dendritic cells
J. Leukoc. Biol.,
December 1, 2005;
78(6):
1397 - 1407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-T. Zilber, N. Setterblad, T. Vasselon, C. Doliger, D. Charron, N. Mooney, and C. Gelin
MHC class II/CD38/CD9: a lipid-raft-dependent signaling complex in human monocytes
Blood,
November 1, 2005;
106(9):
3074 - 3081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Monti, K. J. Savage, J. L. Kutok, F. Feuerhake, P. Kurtin, M. Mihm, B. Wu, L. Pasqualucci, D. Neuberg, R. C. T. Aguiar, et al.
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
Blood,
March 1, 2005;
105(5):
1851 - 1861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Li, C. J. Workman, S. M. Martin, and D. A. A. Vignali
Biochemical Analysis of the Regulatory T Cell Protein Lymphocyte Activation Gene-3 (LAG-3; CD223)
J. Immunol.,
December 1, 2004;
173(11):
6806 - 6812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. El Fakhry, M. Bouillon, C. Leveille, A. Brunet, H. Khalil, J. Thibodeau, and W. Mourad
Delineation of the HLA-DR Region and the Residues Involved in the Association with the Cytoskeleton
J. Biol. Chem.,
April 30, 2004;
279(18):
18472 - 18480.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|